ARCHIVES

Translplants Not Best Choice in Subset of ALL Patients

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities; Program Announcements Released By NCI

May 21, 1999

Perifosine Increases PFS In Phase II Study

December 30, 2011

Cancer Centers Program To Implement Most Changes Sought By review Group

December 13, 1996

Trials Approved by NCI CTEP Last Month

November 25, 2011

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

Paul Okunieff Named Director At UF Shands Cancer Center

October 16, 2009